179384 Barriers to pediatric lead screening: A web-based survey of Vermont pediatricians

Tuesday, October 28, 2008: 3:05 PM

Britton C. Keeshan, MPH , University of Vermont College of Medicine, Burlington, VT
Catherine Avener, MS , University of Vermont College of Medicine, Burlington, VT
Amanda Abramson , University of Vermont College of Medicine, Burlington, VT
Jillian Brennan , University of Vermont College of Medicine, Burlington, VT
Elizabeth R. Hill , University of Vermont College of Medicine, Burlington, VT
Jeffrey Maclean, MS , University of Vermont College of Medicine, Burlington, VT
Sanchit Maruti, MS , University of Vermont College of Medicine, Burlington, VT
Kelly Mebust , University of Vermont College of Medicine, Burlington, VT
Jan Carney, MD, MPH , University of Vermont College of Medicine, Burlington, VT
Wendy Davis, MD , Maternal and Child Health, Vermont Department of Health, Burlington, VT
Austin Sumner, MD, MPH , Environmental Health, Vermont Department of Health, Burlington, VT
The pernicious effects of lead on the health of children are well documented. Currently, the Vermont Department of Health (VDH) recommends screening all 12 and 24 month-old children for elevated blood lead levels (BLLs). However, in 2006, only 41.4% of 24 month-old Vermont children were screened. To identify barriers to screening, a web-based survey was distributed to all Vermont primary care pediatricians. Childhood lead and immunization registries were used to divide VT pediatricians into higher and lower blood lead screening groups. 73.5% (72) of VT pediatricians responded to the survey, with the most common reported barrier to screening being parental opposition (79.2%). VT pediatricians were more likely to be in the lower screening group if they reported negative health outcomes began with BLLs >10μg/dL (OR 3.64, 95%CI 1.12-11.99), reported practicing in Chittenden County (OR 3.34, 95%CI 1.14-9.78), or reported disagreeing with the VDH universal blood lead screening recommendation (OR 4.90, 95%CI 1.66-15.50). Adjusted analysis indicated the most significant determinants of lower screening rates were male sex, a perceived dangerous BLL >10μg/dL and low self-reported Medicaid population. While the underlying causes of these associations are not entirely understood, 87.5% of VT pediatricians reported using the VDH as a primary source of information and guidance when establishing office policy. Thus, the VDH has an opportunity to increase BLL screening by VT pediatricians of all 24 month-old children by redesigning its physician education to emphasize significant health risks associated with BLLs ≤10μg/dL.

Learning Objectives:
1) Identify barriers preventing Vermont pediatricians from performing blood lead screening on all 24 month-old children. 2)Identify specific predictors associated with lower blood lead screening rates among Vermont pediatricians. 3) Identify strategies to increase blood lead screening of all 24 month-old children in Vermont based on the identified barriers.

Keywords: Lead, Screening

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I, in collaboration with my colleagues, without any conflicts of interest, have designed the study, collected data, analyzed and interpreted the findings, and subsequently report the aforementioned in the following abstract.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.